Literature DB >> 32348453

Genetic basis and molecular biology of cardiac arrhythmias in cardiomyopathies.

Ali J Marian1, Babken Asatryan2, Xander H T Wehrens3.   

Abstract

Cardiac arrhythmias are common, often the first, and sometimes the life-threatening manifestations of hereditary cardiomyopathies. Pathogenic variants in several genes known to cause hereditary cardiac arrhythmias have also been identified in the sporadic cases and small families with cardiomyopathies. These findings suggest a shared genetic aetiology of a subset of hereditary cardiomyopathies and cardiac arrhythmias. The concept of a shared genetic aetiology is in accord with the complex and exquisite interplays that exist between the ion currents and cardiac mechanical function. However, neither the causal role of cardiac arrhythmias genes in cardiomyopathies is well established nor the causal role of cardiomyopathy genes in arrhythmias. On the contrary, secondary changes in ion currents, such as post-translational modifications, are common and contributors to the pathogenesis of arrhythmias in cardiomyopathies through altering biophysical and functional properties of the ion channels. Moreover, structural changes, such as cardiac hypertrophy, dilatation, and fibrosis provide a pro-arrhythmic substrate in hereditary cardiomyopathies. Genetic basis and molecular biology of cardiac arrhythmias in hereditary cardiomyopathies are discussed. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author(s) 2020. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  Genetics • Cardiomyopathy • Arrhythmias • Ion channels • Electrophysiology • Sudden death

Year:  2020        PMID: 32348453      PMCID: PMC7341170          DOI: 10.1093/cvr/cvaa116

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  267 in total

1.  Protein Phosphatase 2A Regulates Cardiac Na+ Channels.

Authors:  Mona El Refaey; Hassan Musa; Nathaniel P Murphy; Ellen R Lubbers; Michel Skaf; Mei Han; Omer Cavus; Sara N Koenig; Michael J Wallace; Daniel Gratz; Elisa Bradley; Katherina M Alsina; Xander H T Wehrens; Thomas J Hund; Peter J Mohler
Journal:  Circ Res       Date:  2019-03       Impact factor: 17.367

2.  Missense mutations in the rod domain of the lamin A/C gene as causes of dilated cardiomyopathy and conduction-system disease.

Authors:  D Fatkin; C MacRae; T Sasaki; M R Wolff; M Porcu; M Frenneaux; J Atherton; H J Vidaillet; S Spudich; U De Girolami; J G Seidman; C Seidman; F Muntoni; G Müehle; W Johnson; B McDonough
Journal:  N Engl J Med       Date:  1999-12-02       Impact factor: 91.245

3.  SCN5A mutations associate with arrhythmic dilated cardiomyopathy and commonly localize to the voltage-sensing mechanism.

Authors:  William P McNair; Gianfranco Sinagra; Matthew R G Taylor; Andrea Di Lenarda; Debra A Ferguson; Ernesto E Salcedo; Dobromir Slavov; Xiao Zhu; John H Caldwell; Luisa Mestroni
Journal:  J Am Coll Cardiol       Date:  2011-05-24       Impact factor: 24.094

4.  Inhibition of CaMKII phosphorylation of RyR2 prevents inducible ventricular arrhythmias in mice with Duchenne muscular dystrophy.

Authors:  Sameer Ather; Wei Wang; Qiongling Wang; Na Li; Mark E Anderson; Xander H T Wehrens
Journal:  Heart Rhythm       Date:  2012-12-12       Impact factor: 6.343

5.  Non-sustained ventricular tachycardia in hypertrophic cardiomyopathy: an independent marker of sudden death risk in young patients.

Authors:  Lorenzo Monserrat; Perry M Elliott; Juan R Gimeno; Sanjay Sharma; Manuel Penas-Lado; William J McKenna
Journal:  J Am Coll Cardiol       Date:  2003-09-03       Impact factor: 24.094

6.  Gender-specific differences in major cardiac events and mortality in lamin A/C mutation carriers.

Authors:  Ingrid A W van Rijsingen; Eline A Nannenberg; Eloisa Arbustini; Perry M Elliott; Jens Mogensen; Johanna F Hermans-van Ast; Anneke J van der Kooi; J Peter van Tintelen; Maarten P van den Berg; Maurizia Grasso; Alessandra Serio; Sharon Jenkins; Camilla Rowland; Pascale Richard; Arthur A M Wilde; Andreas Perrot; Sabine Pankuweit; Aeilko H Zwinderman; Philippe Charron; Imke Christiaans; Yigal M Pinto
Journal:  Eur J Heart Fail       Date:  2012-11-25       Impact factor: 15.534

7.  Association Between Titin Loss-of-Function Variants and Early-Onset Atrial Fibrillation.

Authors:  Seung Hoan Choi; Lu-Chen Weng; Carolina Roselli; Honghuang Lin; Christopher M Haggerty; M Benjamin Shoemaker; John Barnard; Dan E Arking; Daniel I Chasman; Christine M Albert; Mark Chaffin; Nathan R Tucker; Jonathan D Smith; Namrata Gupta; Stacey Gabriel; Lauren Margolin; Marisa A Shea; Christian M Shaffer; Zachary T Yoneda; Eric Boerwinkle; Nicholas L Smith; Edwin K Silverman; Susan Redline; Ramachandran S Vasan; Esteban G Burchard; Stephanie M Gogarten; Cecelia Laurie; Thomas W Blackwell; Gonçalo Abecasis; David J Carey; Brandon K Fornwalt; Diane T Smelser; Aris Baras; Frederick E Dewey; Cashell E Jaquish; George J Papanicolaou; Nona Sotoodehnia; David R Van Wagoner; Bruce M Psaty; Sekar Kathiresan; Dawood Darbar; Alvaro Alonso; Susan R Heckbert; Mina K Chung; Dan M Roden; Emelia J Benjamin; Michael F Murray; Kathryn L Lunetta; Steven A Lubitz; Patrick T Ellinor
Journal:  JAMA       Date:  2018-12-11       Impact factor: 56.272

8.  Mutation in the γ2-subunit of AMP-activated protein kinase stimulates cardiomyocyte proliferation and hypertrophy independent of glycogen storage.

Authors:  Maengjo Kim; Roger W Hunter; Lorena Garcia-Menendez; Guohua Gong; Yu-Ying Yang; Stephen C Kolwicz; Jason Xu; Kei Sakamoto; Wang Wang; Rong Tian
Journal:  Circ Res       Date:  2014-02-06       Impact factor: 17.367

9.  Rare coding TTN variants are associated with electrocardiographic QT interval in the general population.

Authors:  Ashish Kapoor; Kiranmayee Bakshy; Linda Xu; Priyanka Nandakumar; Dongwon Lee; Eric Boerwinkle; Megan L Grove; Dan E Arking; Aravinda Chakravarti
Journal:  Sci Rep       Date:  2016-06-20       Impact factor: 4.379

10.  Identification of Myocardial Disarray in Patients With Hypertrophic Cardiomyopathy and Ventricular Arrhythmias.

Authors:  Rina Ariga; Elizabeth M Tunnicliffe; Sanjay G Manohar; Masliza Mahmod; Betty Raman; Stefan K Piechnik; Jane M Francis; Matthew D Robson; Stefan Neubauer; Hugh Watkins
Journal:  J Am Coll Cardiol       Date:  2019-05-28       Impact factor: 24.094

View more
  17 in total

Review 1.  The role of junctophilin proteins in cellular function.

Authors:  Stephan E Lehnart; Xander H T Wehrens
Journal:  Physiol Rev       Date:  2022-01-10       Impact factor: 37.312

Review 2.  Role of Ca2+ in healthy and pathologic cardiac function: from normal excitation-contraction coupling to mutations that cause inherited arrhythmia.

Authors:  Joshua A Keefe; Oliver M Moore; Kevin S Ho; Xander H T Wehrens
Journal:  Arch Toxicol       Date:  2022-10-10       Impact factor: 6.168

3.  Frequency, Penetrance, and Variable Expressivity of Dilated Cardiomyopathy-Associated Putative Pathogenic Gene Variants in UK Biobank Participants.

Authors:  Ravi A Shah; Babken Asatryan; Ghaith Sharaf Dabbagh; Nay Aung; Mohammed Y Khanji; Luis R Lopes; Stefan van Duijvenboden; Anthony Holmes; Daniele Muser; Andrew P Landstrom; Aaron Mark Lee; Pankaj Arora; Christopher Semsarian; Virend K Somers; Anjali T Owens; Patricia B Munroe; Steffen E Petersen; C Anwar A Chahal
Journal:  Circulation       Date:  2022-06-16       Impact factor: 39.918

Review 4.  Arrhythmias as Presentation of Genetic Cardiomyopathy.

Authors:  J Lukas Laws; Megan C Lancaster; M Ben Shoemaker; William G Stevenson; Rebecca R Hung; Quinn Wells; D Marshall Brinkley; Sean Hughes; Katherine Anderson; Dan Roden; Lynne W Stevenson
Journal:  Circ Res       Date:  2022-05-26       Impact factor: 23.213

5.  Inflammation and Immune Response in Arrhythmogenic Cardiomyopathy: State-of-the-Art Review.

Authors:  Babken Asatryan; Angeliki Asimaki; Andrew P Landstrom; Mohammed Y Khanji; Katja E Odening; Leslie T Cooper; Francis E Marchlinski; Anna R Gelzer; Christopher Semsarian; Tobias Reichlin; Anjali T Owens; C Anwar A Chahal
Journal:  Circulation       Date:  2021-11-15       Impact factor: 39.918

6.  Molecular Genetic Basis of Hypertrophic Cardiomyopathy.

Authors:  A J Marian
Journal:  Circ Res       Date:  2021-05-13       Impact factor: 17.367

7.  Haploinsufficiency of Tmem43 in cardiac myocytes activates the DNA damage response pathway leading to a late-onset senescence-associated pro-fibrotic cardiomyopathy.

Authors:  Leila Rouhi; Sirisha M Cheedipudi; Suet Nee Chen; Siyang Fan; Raffaella Lombardi; Xiaofan Chen; Cristian Coarfa; Matthew J Robertson; Priyatansh Gurha; Ali J Marian
Journal:  Cardiovasc Res       Date:  2021-09-28       Impact factor: 13.081

Review 8.  Mechanisms underlying pathological Ca2+ handling in diseases of the heart.

Authors:  Satadru K Lahiri; Yuriana Aguilar-Sanchez; Xander H T Wehrens
Journal:  Pflugers Arch       Date:  2021-01-05       Impact factor: 3.657

Review 9.  CMR-Based Risk Stratification of Sudden Cardiac Death and Use of Implantable Cardioverter-Defibrillator in Non-Ischemic Cardiomyopathy.

Authors:  Laura Keil; Céleste Chevalier; Paulus Kirchhof; Stefan Blankenberg; Gunnar Lund; Kai Müllerleile; Christina Magnussen
Journal:  Int J Mol Sci       Date:  2021-07-01       Impact factor: 5.923

10.  Variants in MHY7 Gene Cause Arrhythmogenic Cardiomyopathy.

Authors:  Valentina Ferradini; Luca Parca; Annamaria Martino; Chiara Lanzillo; Elisa Silvetti; Leonardo Calò; Stefano Caselli; Giuseppe Novelli; Manuela Helmer-Citterich; Federica Carla Sangiuolo; Ruggiero Mango
Journal:  Genes (Basel)       Date:  2021-05-22       Impact factor: 4.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.